Integrins use divalent cations, held within a novel 'MIDAS' motif, for ligand binding. It is proposed that a missing coordination site for the cation is provided by a critical acidic residue in the ligand.
Integrins are cell-surface glycoproteins -each composed of an and subunit -that mediate cell interactions with a variety of ligands. Such ligands include extracellular matrix proteins, counter-receptors on other cells, plasma proteins and microbial pathogens. As integrins function in such pathological processes as inflammation, thrombosis and tumor metastasis, agents that block integrin-ligand interactions could be of great therapeutic value, and many laboratories have sought to define the structures involved. Despite their obvious interest, however, these large and complex proteins have been unwilling subjects for X-ray crystallographic analysis. Now Lee et al. [1] have determined the crystal structure of a ligand-binding domain within the oaM subunit of the leukocyte integrin CR3. In another significant advance, Jones et al. [2] have determined the partial structure of an integrin ligand, the vascular cell-adhesion molecule VCAM-1.
A ligand-binding domain within an integrin oz subunit
The aM13 2 integrin (also called CR3, CDllb/CD18 or Mac-1) is present on phagocytic cells and is involved both in leukocyte adhesion to endothelium and in the internalization of opsonized microorganisms. CR3 ligands include the complement component iC3b, the intercellular adhesion molecule ICAM-1, and the coagulation factors fibrinogen and factor X. Within CR3, the olM subunit contains a 200 amino-acia inserted domain, referred to by many investigators as the I domain. Similar I-domain regions are found in 6 of the 15 known integrin ao subunits. As they show homology to the collagen-binding A domains of von Willebrand factor, it had long been suspected that the integrin I (or A) domains were involved in ligand binding. This was first demonstrated when function-blocking monoclonal antibody epitopes were mapped to the aM I-domain region [3] , and site-specific mutations within the I domain abolished integrin attachment to ligand [4] . More recently, isolated integrin I domains were synthesized as bacterial fusion proteins, and were shown by five different groups to bind directly to a variety of ligands (listed in [5] ).
Lee et al. [1] have determined the structure of such a recombinant protein. The integrin otaM I domain consists of a central sheet surrounded by seven helices (Fig. 1) . The amino and carboxyl termini of the recombinant peptide emerge from the base of the globular domain, where they would presumably be joined to the body of the o subunit. Situated at the opposite pole is a single magnesium ion, coordinated by five oxygenated amino acids -the sequence DXSXS (in the single-letter amino-acid code, with X representing any amino acid), plus non-contiguous aspartate and threonine residues downstream. A similar pattern of oxygenated residues, which the authors characterize as the 'metal ion-dependent adhesion site' (MIDAS) motif, is present within all integrin I domains, and there is strong evidence for its role in integrin-ligand interactions. Divalent cations are critical for integrin interactions with almost all ligands [6] , and mutagenesis of amino acids that comprise the MIDAS motif is known to prevent ligand binding [4, 7] . Interestingly, within the crystal structure, an acidic residue derived from a neighboring I domain provides a sixth magnesium coordination site (Fig. 2) . The authors propose that, under physiological conditions, the sixth coordination site might be provided by an acidic ligand residue.
The paper by Lee et al. [1] provides a first view of integrin-ligand interactions, but the picture is far from complete and several issues remain to be explored. Many integrins, including the receptor for VCAM-1 (the structure of which is described below), do not contain I domains within their a subunits. For those integrins that do have I domains, specificity for particular ligands strands (see Fig. 3 ). This structure for VCAM-1 is the first to be reported for a member of the integrin-binding subgroup of the immunoglobulin superfamily. Thus, this finding helps bring into focus some distinctive features of this immunoglobulin subgroup, which includes VCAM-1, MadCAM, and ICAMs -1, -2 and -3. Each has a conserved extra disulfide bond, which is now shown in the VCAM-1 domain 1 to link the BC and FG loops at the top of the immunoglobulin domain barrel. Most importantly, each also has an integrin-binding motif, related to QIDSPL, shown in the VCAM-1 domain 1 structure to be prominently displayed at the end of the CD loop (Fig. 3) . Within the QIDSPL sequence, mutagenesis has consistently shown that Asp 40 may be most critical residue for ligand binding [11, 12] .
must involve non-conserved amino acids as well as the conserved MIDAS residues. Furthermore, the 'MIDAS touch' may be less relevant for unusual integrin ligands, such as the pathogen echovirus 1, as their binding is cation-independent. The eventual development of selective therapeutic agents will depend on understanding how specific integrins fit their particular ligands.
Several lines of evidence indicate that regions within the as well as the ot subunits of integrins are involved in integrin-ligand interactions (reviewed in [6] ). The DXSXS motif is present in all eight of the known integrin subunits, at a putative binding site implicated by ligand crosslinking studies. Replacement of these oxygenated residues within the subunit abolishes ligand binding, even for I domain-containing integrins such as CR3 [8] . Thus, it is a quite fascinating possibility that integrin subunits might also contain a MIDAS-like motif within a ligand-binding region that is structurally related to the ot subunit I domain [1] .
An integrin recognition site within the ligand VCAM-1
Many integrin ligands contain an Arg-Gly-Asp (RGD) motif that is essential for cell adhesion [9] . Within the tenth type-II repeat of fibronectin, the RGD is present within a conformationally mobile loop [10] , thus allowing ready accessibility for integrin recognition. Although there is no obvious sequence similarity between fibronectin type-III repeats and immunoglobulin domains, they are topologically quite similar [10] : each is barrel shaped, with two facing sheets, and each sheet is composed of three or four antiparallel strands.
Analogous to the location of the RGD sequence within the fibronectin type-III repeat, the recent crystal structure of VCAM-1 immunoglobulin domains 1 and 2 by Although the QIDSPL sequence is critical, it obviously does not solely determine integrin specificity, as the QIDS sequence in VCAM-1 can be replaced by GIET (derived from ICAM-1) without preventing binding to the receptor, VLA-4 [11] . Several other residues on the face of the CFG 13 sheet in the VCAM domain 1 also contribute to ligand binding (Fig. 3) . This finding points to an emerging trend among immunoglobulin-like proteins involved in adhesive interactions, as the CFG faces of the adhesive proteins CD2 [13] and E-cadherin [14] also contain critical sites for ligand binding.
Within the subgroup of integrin-binding immunoglobulin domain proteins, domain-1 BC loops and domain-2 C'E loops show important differences among MAdCAM, VCAM and the three ICAMs, and thus could be critical elements for determining ligand specificity [2] . It is intriguing that the shortest domain-i BC loops and domain-2 C'E loops are found in the ICAMs, which are ligands for integrins that contain I domains. In contrast, the longer BC and C'E loops of VCAM and MadCAM correlate with binding to 413 1 and oL4 37 integrins that lack I domains. The VCAM-1 domain-2 structure also contains a typical immunoglobulin-type topology, but it has not yet been found to contain residues directly implicated in ligand binding. Nonetheless, the proximity of the domain-2 C'E and FG loops to the integrin-binding region in domain 1 suggests possible targets for future mutagenesis.
So far, integrin ligands all contain acidic residues (usually aspartate, sometimes glutamate) as a key feature of their integrin-binding motifs. As is true for the RGD and QIDSPL motifs described above, we predict that other recognition motifs (such as the LDV site within fibronectin, recognised by VLA-4) will also be found within flexible loops, where they may be available for integrin recognition. In this regard, it is quite intriguing to find that each of five different cadherins all contain aspartates in the middle of immunoglobulin-like CD loops [14] , considering the recent evidence that a cadherin can be recognized by an integrin [15] .
The notion that all integrins may contain at least one, and sometimes two MIDAS motifs, neatly fits the concept of acidic ligand residues providing missing divalent cation coordinations. This paradigm represents an important start towards understanding integrin-ligand interactions. An obvious challenge for the future will be to coordinate the contributions of both et and 13 integrin chains to ligand binding. An even bigger challenge for structural biologists will be to elucidate the perhaps subtle conformational changes that accompany integrin activation, and to understand the substantial conformational changes that apparently occur as a result of ligand binding and contribute to signaling from the outside of the cell to the inside.
